Beta-Glucan Market

In addition to the food and beverage sector, the beta-glucan market has expanded into pharmaceuticals, animal feed, and cosmetics, showcasing its versatility and potential for innovation. The pharmaceutical industry, in particular, has shown interest in beta-glucans for their potential in cancer treatment and as adjuvants in vaccines. Moreover, advancements in extraction technologies and increasing research and development activities have paved the way for the development of new and improved beta-glucan products. However, the market also faces challenges such as high production costs and regulatory hurdles, which could hinder its growth to some extent. Nonetheless, with ongoing research and growing consumer demand, the beta-glucan market is expected to continue its upward trajectory in the coming years.

To know about the assumptions considered for the study download the pdf brochure

Major manufacturers in this market are based in North America and Europe. Tate & Lyle PLC (UK), Kerry Group plc (Ireland), DSM Firmenich  (Netherlands), Merck (Germany), Lesaffre  (France), Kemin Industries (US), Angel Yeast Co. Ltd (China), Lallemand (Canada), Associated British Foods Plc (UK), Biorigin (Brazil), Ceapro Inc. (Canada), Specialty Biotech Co., Ltd. (US), Alltech (US), Garuda International Inc. (US), and Leiber (Germany). Some key players in the beta-glucan market have implemented different growth tactics to enhance their market position. These strategies encompass introducing new products, forming contracts, establishing partnerships, engaging in mergers and acquisitions, and pursuing new product development initiatives to broaden their footprint in the beta-glucan market.

Other players include  VW-Ingredients (Netherlands), Super Beta Glucan(US), GlycaNova AS  (Norway), NutriScience Innovations, LLC (US), Algalíf Iceland hf. (Iceland), ABAC R&D  (Switzerland), Natural Biologics (New Zealand), BENEO (Germany), L&P Food Ingredient Co., Ltd. (China), Beta Bio Technology sp. z o. o (Poland).

Tate & Lyle PLC

Tate & Lyle PLC is a prominent supplier of high-quality ingredients and solutions for the food & beverage, pharmaceutical, industrial, and personal care sectors. Organized into three main global divisions—food & beverage solutions, sucralose, and Primary Products Europe—the company offers beta-glucan products in the food & beverage solutions division for use in nutritional supplements and personal care.

With a strong presence in the US and Europe, Tate & Lyle also has operations in Latin America and the Asia Pacific region. The company operates internationally through various subsidiaries, including Tate & Lyle Argentina SA, Tate & Lyle Sweden AB, Tate & Lyte Brasil do SA, Tate & Lyle Chile Commercial Ltd, Tate & Lyle Trading (Shanghai) Ltd. in China, Tate & Lyle Italia Spa, Tate & Lyle Netherlands BV, and Tate & Lyle Ingredients Americas, LLC in the US. Employing 3,604 people across 122 countries, Tate & Lyle serves a broad customer base through its 58 facilities, offices, Customer Innovation and Collaboration Centers, and 16 laboratories worldwide. This extensive network underscores Tate & Lyle's commitment to innovation, collaboration, and delivering value to its global customers.

Kerry Group PLC

Kerry Group PLC, headquartered in Ireland, is a publicly-traded company specializing in the fields of taste and nutrition. The company operates primarily through two core business segments: taste & nutrition and dairy Ireland. Within its taste & nutrition segment, Kerry Group offers beta-glucan products under its Wellmune brand. These beta-glucan products are predominantly targeted towards the food & beverage, pharmaceutical, and dietary supplement industries.

With a global reach spanning over 140 countries, Kerry Group maintains a presence across North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The company operates an extensive network of 147 manufacturing facilities in 32 countries across all continents. Some notable subsidiaries of Kerry Group include Oakhouse Foods in the UK, Island Oasis Inc in the US, Sucrest GmbH in Germany, Ganeden in the US, Big Train Inc in the US, Oregon Chai in the US, and Peyesa Biotech SA in Spain.

DSM Fimenich

DSM, headquartered in the Netherlands, stands as a leading provider of science-based solutions in health and nutrition. Committed to innovation and sustainability, DSM delivers a broad spectrum of products spanning various sectors, including food, pharmaceuticals, animal nutrition, and personal care. Meanwhile, Ermenich International SA, based in Switzerland, has built a solid reputation over a century as a pioneer in creating fragrances, flavors, and ingredients. In May 2023, DSM and Ermenich International SA merged to form dam firmenich, based in the Netherlands. This strategic alliance between the two companies aims to position dam firmenich as a premier partner in innovation across the nutrition, beauty, and well-being sectors. With a combined revenue nearing USD 13.17 billion, the newly formed entity operates in four key segments: perfumery & beauty, taste, texture & health, health, nutrition & care, and animal nutrition & health.

Under its health, nutrition & care segment, dam firmenich offers a range of beta-glucans and stands as one of the largest global producers of vitamins. The company boasts a strong global presence across major regions, including North America, Europe, Latin America, Asia Pacific, and Africa, with a network of over 200 sites and offices in nearly 50 countries.

Related Reports:

Beta-Glucan Market by Category (Soluble, Insoluble), Source (Cereal & Grains, Mushroom, Yeast, Seaweed), Application (Food & Beverage, Dietary Supplement, Personal Care, Cosmetics, Pharmaceutical, Animal Feed), Type and Region - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]